NCT00803790View on ClinicalTrials.gov

A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)

PHASE1CompletedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Osteoporosis
Interventions
DRUG

alendronate sodium+vitamin D combination

A single dose tablet of 70mg alendronate sodium+5600 IU vitamin D combination tablet in one treatment period of each sequence.

DRUG

Comparator: alendronate

A single dose tablet of 70mg alendronate in one treatment period of each sequence.

DIETARY_SUPPLEMENT

Comparator: Vitamin D

Two tablets of 2800 IU vitamin D, totaling 5600 IU, in one treatment period of each sequence.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00803790 - A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253) | Biotech Hunter | Biotech Hunter